The aim of this study was primarily to examine the expression of HER2/neu in normal human oral epithelium and patients with HNSCC, to validate the controversial results of various studies and to determine whether or not HER2/neu could be considered as a useful marker for head and neck cancer. This evidence concerns the gene ERBB2 and head and neck cancer.